Over the current book year the company from New Brunswick could achieve a revenue around 91.54 billion USD (consensus estimates). This is quite more than 2020's revenue of 82.58 billion USD.
The analysts expect for 2021 a net profit of 25.29 billion USD. For this year the consensus of Johnson & Johnson 's result per share is a profit of 9.5 USD. Based on this the price/earnings-ratio is 17.13.
Analysts expect a dividend of 4.26 USD per share. Johnson & Johnson 's dividend yield thus equals 2.62 percent. The average dividend yield of the health care companies is a moderate 0.49 percent.
Johnson & Johnson 's market capitalization is based on the number of outstanding shares around 428.47 billion USD. The Johnson & Johnson stock was the past 12 months quite volatile. Since last February the stock is 20 percent higher. This year the stock price moved between 109 and 174 dollar.
Click here for dividend Johnson & Johnson. On Thursday the stock closed at 162.76 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.